Primary Site >> Stomach Cancer
Gene >> CHFR
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Epigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer. PMID: 14695171 |
Ref: Promoter hypermethylation of the Chfr gene in neoplastic and non-neoplastic gastric epithelia. PMID: 15138487 Ref: Promoter hypermethylation and silencing of CHFR mitotic stress checkpoint gene in human gastric cancers. PMID: 15201973 |
Ref: Hypermethylation of Chfr and hMLH1 in gastric noninvasive and early invasive neoplasias. PMID: 15735977 |
Ref: Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. PMID: 16482617 Ref: The significance of aberrant CHFR methylation for clinical response to microtubule inhibitors in gastric cancer. PMID: 16568372 Ref: Aberrant methylation of the CHFR gene in digestive tract cancer. PMID: 16827108 |
Ref: Molecular analysis of primary gastric cancer, corresponding xenografts, and 2 novel gastric carcinoma cell lines reveals novel alterations in gastric carcinogenesis. PMID: 17376510 Ref: Aberrant methylation of p16 predicts candidates for 5-fluorouracil-based adjuvant therapy in gastric cancer patients. PMID: 18008030 |
Ref: DNA methylation profiles of gastric carcinoma characterized by quantitative DNA methylation analysis. PMID: 18158559 Ref: The anti-proliferative effects of the CHFR depend on the forkhead associated domain, but not E3 ligase activity mediated by ring finger domain. PMID: 18335050 Ref: Mechanism and pathobiologic implications of CHFR promoter methylation in gastric carcinoma. PMID: 18763281 |
Ref: Checkpoint with forkhead-associated and ring finger promoter hypermethylation correlates with microsatellite instability in gastric cancer. PMID: 19469003 |
Ref: Aberrant gene methylation in the lymph nodes provides a possible marker for diagnosing micrometastasis in gastric cancer. PMID: 19957042 Ref: Promoter methylation of CHFR gene in gastric carcinoma tissues detected using two methods. PMID: 20109344 Ref: Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma. PMID: 21302620 |
Ref: Pathobiologic implications of methylation and expression status of Runx3 and CHFR genes in gastric cancer. PMID: 20300977 Ref: Aberrant gene methylation is a biomarker for the detection of cancer cells in peritoneal wash samples from advanced gastric cancer patients. PMID: 21409489 |
Ref: Association between CHFR methylation and chemosensitivity of paclitaxel in advanced gastric cancer. PMID: 24639283 Ref: [Promoter region methylation of DNA damage repair genes in human gastric cancer]. PMID: 25331470 |
Ref: Integrated analysis of cancer-related pathways affected by genetic and epigenetic alterations in gastric cancer. PMID: 24510342 Ref: Predictive value of CHFR and MLH1 methylation in human gastric cancer. PMID: 24748501 |
Ref: High-definition CpG methylation of novel genes in gastric carcinogenesis identified by next-generation sequencing. PMID: 26769141 Ref: Association between CHFR gene hypermethylation and gastric cancer risk: a meta-analysis. PMID: 27994471 |
Ref: Clinicopathological significance of CHFR promoter methylation in gastric cancer: a meta-analysis. PMID: 29515792 |